CANDELARIA MCELHINNY: Open Payments
NPI 1922363274 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 63 payments from 23 companies in 2025. Trend: 2023 $741 · 2024 $1,642 · 2025 $2,118
Food & beverage: $1,118Long term medical supply or device loan: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,187 |
| ABBVIE INC. | 7 | $142 |
| PFIZER INC. | 5 | $130 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| Janssen Biotech, Inc. | 3 | $77 |
| Lilly USA, LLC | 2 | $56 |
| SHIELD THERAPEUTICS INC | 2 | $42 |
| Incyte Corporation | 2 | $42 |
| Astellas Pharma US Inc | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: KISQALI, IBRANCE, EPKINLY, RYBREVANT, TAGRISSO, ACCRUFER, XTANDI, VENCLEXTA.
Industry payments across NY — which companies pay providers there.
